BioNTech stock trades at EUR 78.55 in Friday evening session
Published on 10/30/2026 at 19:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUpcoming Results Keep Investors Focused
- BioNTech is scheduled to publish its third-quarter 2026 results on November 3.
- The company will also provide a corporate update during its investor webcast.
BioNTech stock traded at EUR 78.55 on Lang & Schwarz at 7:41 p.m. CEST on Friday, October 30. The quote provides a reference point ahead of the company's scheduled third-quarter update.
BioNTech said in a press release published on October 20 that it will announce its third-quarter 2026 financial results on Tuesday, November 3. The investor call and webcast are scheduled for 8:00 a.m. Eastern Time, or 2:00 p.m. Central European Time.
Results Set the Next Catalyst
The upcoming release will give investors the next reported view of BioNTech's operating performance and corporate plans. The company describes its business as focused on investigative therapies for cancer and other serious diseases, with programs spanning immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies.
Investors can follow the real-time quote of BioNTech stock for subsequent trading updates.
The broader U.S. market context can be followed through the S&P 500.
More news and analyses are available on BioNTech stock.
BioNTech SE at a Glance
- Company: BioNTech SE
- ISIN: US09075V1026
- Trading venue: Lang & Schwarz
- Quote: EUR 78.55 on October 30, 2026, at 7:41 p.m. CEST
- Next results: November 3, 2026
